Doing business with the DoD (then and now)

Lee Drucker | September 28, 2015

Small businesses face particular challenges when endeavoring to protect their patent rights and rights to technical data. The committee report noted instances where the DoD gave another contractor access to intellectual property so they could “reverse engineer”and manufacture a patented invention. If a contractor feels his or her invention has been used unlawfully, the contractor’s only recourse, according to the report, is to sue through U.S. Federal Court –an inordinately expensive and time-consuming process.

Read More

Panel Discussion on Protecting Your Company

Lee Drucker | September 18, 2015

I recently participated in a panel discussion at the Converge conference. It produced a discussion that I think can be useful for innovators in the life sciences space. MedCity News summarized the event here.

Read More

Protecting Yourself as a Small Business Contractor with the Department of Defense

Lee Drucker | September 10, 2015

Fred Lisy is president of Orbital Research Inc., which conducts research on and product development of medical devices and military weapons technology. Founded in 1991, this small company of 16 employees has been contracting with the Department of Defense for more than 20 years, mainly with the U.S. Army, U.S. Navy and U.S. Air Force.

“You can’t be risk averse and work with DoD,” he says, which is one reason he maintains about 30 to 50 percent of company revenue in commercial as opposed to government ventures. That being said, he’s also quick to note the best way to protect one’s self as a small business is to keep learning and asking questions. The more you know, the safer you’ll be.

Read More

Litigation Finance Interview for MedCity News

Lee Drucker | August 25, 2015

I was recently interviewed by MedCity News in anticipation of a panel that I will be speaking on at the Converge Conference (Philadelphia September 1 – 2).

“I would speculate that in some situations, the relationship turns into a numbers game. They plug in a number: “What happens if we build out this technology on our own, and what happens if we partner with the entrepreneurial company and own 30 percent?” If they determine it’s more profitable to build the technology on their own, then they disregard the contract and the law.”

Read More

Litigation Finance in Context of WJP Rankings

Lee Drucker | August 18, 2015

Interesting article from The Hill discussing litigation finance in the context of the World Justice Project placing the U.S. 65th in its ranking of affordability and accessibility to its legal system.

Read More

Litigation Finance for Boutique Law Firms

Lee Drucker | August 11, 2015

Several months ago I described how litigation finance can be used by entrepreneurial litigators at large law firms to build sustainable high-end litigation practices outside the traditional route of cultivating relationships with the largest corporations and their general counsel.

Many of the same challenges that I discussed facing young partners at large law firms manifest more acutely at emerging law firms trying to sustain and grow a business as they attract new clients, build brand awareness, manage salaries, and generally maintain operations.

Read More

Is Litigation Finance Right for Your Client?

Lee Drucker | July 29, 2015

Litigation can get expensive, fast. Litigation finance is a funding tool many companies are considering to help cover the fees and expenses related to major legal claims. We at Lake Whillans Litigation Finance have compiled a list of questions to help you determine if your client is a candidate for litigation finance. Is litigation finance…

Read More

Insights from Research on Corporate Venture in Medtech

Lee Drucker | July 2, 2015

Medcity New’s article discussing the findings from our research on which medtech corporate venture arms are the best partners:

“The shift in the stage of investment and where the perceived opportunities in biotech are have had a significant impact. Pharma corporate venture investors have broadened their interest from late stage to earlier stages of investment. Priorities have also shifted from the next blockbuster drug to more personalized treatments.

One of the consistent criticisms of corporate investors is the imperfect balance between strengthening the core business and the investment target.”

Read the article in its entirety here.

Read More

Litigation Finance: 10 Questions to Help Advise Your Client

Lee Drucker | June 24, 2015

We, at Lake Whillans, have been writing a lot about litigation finance in order to provide lawyers and claimholders with a framework for thinking about its use and potential benefits. I thought it might be time to take a break from writing, and provide an analytics tool to help claimholders and their lawyers determine whether litigation finance makes sense for the business.

Read More

Build a Litigation Finance Company (Part 2)

Lee Drucker | June 10, 2015

As we continue to discuss the benefits of using litigation funding, how it can help companies grow, and how it provides new paths for entrepreneurial litigators, I have begun to explain how we at Lake Whillans think about building a quality litigation funding company. The purpose of this series of posts is to share a little about our vision of litigation finance and how we are building our company. If there are any topics that you might be curious to learn about just email me at

In my last post on the topic, I discussed some of the less obvious benefits that are derived from selecting profitable investments. Today, I want to discuss how we think about the Lake Whillans ‘brand’.

Read More
Contact Us

The best way for companies and their counsel to determine if litigation finance is an attractive option is to discuss it with us.